Crozer Health’s Crozer-Chester Medical Center Utilizes Revolutionary, AI-Driven Intraoperative 3D Imaging for Lung Cancer Diagnosis

Crozer-Chester Medical Center in Upland, Pennsylvania is now offering Body Vision’s intraoperative 3D imaging system for earlier, more accurate lung cancer diagnosis. Body Vision’s imaging system uses artificial intelligence (AI) to transform the X-ray images from conventional C-arm equipment – used in most bronchoscopy procedural rooms – into real-time, intraoperative 3D images that allow bronchoscopists to visualize the actual lung lesion and its location during a diagnostic procedure. This allows biopsy from smaller, more difficult-to-access lung lesions at an earlier stage, maximizing the likelihood of an early, definitive diagnosis for lung cancer patients and improving odds for survival.

Intraoperative 3D Imaging: The New Standard in Lung Cancer Diagnostics

Historically, bronchoscopists have been challenged to obtain diagnostic tissue from suspicious lung lesions because they cannot see the lesion and its location during diagnostic bronchoscopy. Body Vision’s intraoperative 3D imaging allows bronchoscopists to see the lesion and its location intraoperatively in real-time, so they can precisely navigate to the lesion and visually confirm that they are taking tissue samples from the lesion during biopsy. There is no other technology readily accessible to bronchoscopists that provides this kind of real-time, intraoperative 3D imaging image-guided biopsy while also being clinically proven to maximize likelihood of diagnosis.

“Body Vision’s 3D intraoperative imaging improves our yields with the Monarch robotic bronchoscope," said Joseph D. Whitlark, M.D., thoracic and robotic surgeon with Crozer Health. “This is game-changing and is helping us save even more lives through early detection.”

According to the American Lung Association, lung cancer is the leading cause of cancer death in the United States and the average five-year survival rate is just 18.6%. Earlier, definitive diagnosis can drastically change survival odds.

About Body Vision Medical

Body Vision Medical is a medical device company specializing in real-time, intraoperative imaging. The company, founded in 2014, is addressing the unmet clinical need for early, definitive lung cancer diagnosis and effective treatment of lung lesions via a minimally-invasive procedure. Body Vision is FDA cleared and CE marked. Over 1,500 patients to date have benefited from their advanced, tomographic imaging. Body Vision Medical is committed to making real-time, intraoperative imaging during diagnostic bronchoscopy the standard of care for each and every potential lung cancer patient. Learn more at: www.bodyvisionmedical.com.